Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cosciens Biopharma Inc (CSCI)

Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,638
  • Shares Outstanding, K 3,176
  • Annual Sales, $ 9,590 K
  • Annual Income, $ -15,310 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.91
  • Price/Sales 1.02
  • Price/Cash Flow N/A
  • Price/Book 1.21
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.01
  • Most Recent Earnings $-0.85 on 08/14/25
  • Next Earnings Date 11/11/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.50 +8.80%
on 09/03/25
4.07 -33.17%
on 08/04/25
-1.10 (-28.80%)
since 08/01/25
3-Month
2.50 +8.80%
on 09/03/25
4.40 -38.18%
on 07/18/25
-1.18 (-30.26%)
since 06/03/25
52-Week
1.96 +38.78%
on 03/13/25
4.61 -40.94%
on 03/19/25
-1.25 (-31.49%)
since 09/03/24

Most Recent Stories

More News
COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore

TORONTO, ONTARIO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“ COSCIENS ” or the “ Company ”), a life sciences company focused on pharmaceutical therapies,...

CSCI.TO : 2.86 (-5.30%)
CSCIF : 2.1700 (+2.12%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma Inc. Announces Leadership Change

TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) (“COSCIENS” or the “Company”), a life science company focused on natural ingredients and...

CSCI.TO : 2.86 (-5.30%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update

COSCIENS voluntarily delists from Nasdaq, while retaining the Company’s listing on the TSX COSCIENS restructuring results in significantly lower cash outflow with operating expenses down 59% vs....

CSCI.TO : 2.86 (-5.30%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update

COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq , while retaining the Company’s listing on the TSX TORONTO, ONTARIO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS...

CSCI.TO : 2.86 (-5.30%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders

CSCI.TO : 2.86 (-5.30%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders

CSCI.TO : 2.86 (-5.30%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders

CSCI.TO : 2.86 (-5.30%)
CSCI : 2.72 (-11.69%)
Goodwood to Nominate New Directors for COSCIENS Biopharma Inc.

/CNW/ - Goodwood Fund and Puccetti Funds Management Inc. (collectively, "Goodwood") announced today that Goodwood has notified COSCIENS Biopharma Inc. (NASDAQ:...

CSCI.TO : 2.86 (-5.30%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update

CSCI.TO : 2.86 (-5.30%)
CSCI : 2.72 (-11.69%)
COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer

CSCI.TO : 2.86 (-5.30%)
CSCI : 2.72 (-11.69%)

Business Summary

COSCIENS Biopharma Inc. is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. COSCIENS Biopharma Inc., formerly known as Aeterna Zentaris Inc., is based...

See More

Key Turning Points

3rd Resistance Point 3.44
2nd Resistance Point 3.21
1st Resistance Point 2.96
Last Price 2.72
1st Support Level 2.49
2nd Support Level 2.26
3rd Support Level 2.01

See More

52-Week High 4.61
Fibonacci 61.8% 3.59
Fibonacci 50% 3.28
Fibonacci 38.2% 2.97
Last Price 2.72
52-Week Low 1.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar